Note to users. If you're seeing this message, it means that your browser cannot find this page's style/presentation instructions -- or possibly that you are using a browser that does not support current Web standards. Find out more about why this message is appearing, and what you can do to make your experience of our site the best it can be.

Science 2 May 1997:
Vol. 276. no. 5313, pp. 671 - 672
DOI: 10.1126/science.276.5313.671b
Prev | Table of Contents | Next

News & Comment

Science and Commerce:
Disclosing Data Can Get You in Trouble

Eliot Marshall

On 10 April, the U.S. Securities and Exchange Commission (SEC) filed insider-dealing charges against two clinical researchers, accusing them of illegally disclosing early, negative results in a trial of a hepatitis-B drug (thymosin alpha 1), allowing friends and relatives to beat the market by selling off stocks.

Read the Full Text

To Advertise     Find Products

Science. ISSN 0036-8075 (print), 1095-9203 (online)